Piramal Pharma Limited (BOM:543635)

Market Cap	220.36B -25.8%
Revenue (ttm)	88.71B -0.9%
Net Income	-1.64B
EPS	-1.24
Shares Out	n/a
PE Ratio	n/a
Forward PE	99.96
Dividend	0.14 (0.09%)
Ex-Dividend Date	Jul 16, 2025

Volume	179,682
Average Volume	193,970
Open	162.50
Previous Close	163.15
Day's Range	159.00 - 168.00
52-Week Range	148.30 - 241.00
Beta	n/a
RSI	54.87
Earnings Date	Jan 28, 2026

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 5,476
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In fiscal year 2025, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.